EC0225

· Endocyte

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EC0225, covering 2012-03-09 to 2012-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of EC0225 for the Treatment of Refractory or Metastatic Tumors [Phase 1]